China SXT Pharmaceuticals (SXTC) Short term Debt (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Short term Debt of $355175.0 for Q1 2026, up 3944.81% year-over-year from $8781.0 in Q1 2025, and up 7836.87% quarter-over-quarter from $4475.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Short term Debt (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Short term Debt history runs 9 years deep, the most recent figure standing at $355175.0 for Q1 2026.
- In Q1 2026, Short term Debt rose 3944.81% year-over-year to $355175.0; the TTM figure through Mar 2026 stood at $355175.0 (up 3944.81% YoY), while the FY2026 annual figure was $355175.0, up 3944.81% from the prior year.
- Short term Debt for Q1 2026 stood at $355175.0, up from $4475.0 in the prior quarter.
- The five-year high for Short term Debt was $1.2 million in Q3 2022, with the low at $4475.0 in Q3 2025.
- The 5-year median for Short term Debt is $167453.0 (2023), against an average of $328272.8.
- The sharpest annual moves came in 2022 and 2024: Short term Debt sank 99.91% in 2022, then jumped 11960.87% in 2024.
- China SXT Pharmaceuticals' Short term Debt stood at $1.2 million in 2022, then sank by 99.52% to $5822.0 in 2023, then surged by 11960.87% to $702184.0 in 2024, then tumbled by 99.36% to $4475.0 in 2025, then surged by 7836.87% to $355175.0 in 2026.
- Business Quant data shows SXTC's Short term Debt at $355175.0 in Q1 2026, $4475.0 in Q3 2025, and $8781.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | China SXT Pharmaceuticals | 35,343.36 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,175.00 |
| Sep 30, 2025 | 4,475.00 |
| Mar 31, 2025 | 8,781.00 |
| Sep 30, 2024 | 702,184.00 |
| Mar 31, 2024 | 493,054.00 |
| Sep 30, 2023 | 5,822.00 |
| Mar 31, 2023 | 167,453.00 |
| Sep 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 11,404.00 |
| Sep 30, 2021 | 2.12 Mn |
| Mar 31, 2021 | 12.15 Mn |
| Sep 30, 2020 | 45,757.00 |
| Mar 31, 2020 | 6.64 Mn |
| Sep 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 2.48 Mn |
| Sep 30, 2018 | 205,452.00 |